Hematology
Hemophilia A: Controlled Is Not the Same as Unburdened.
KEEP heard from 41 adults with confirmed hemophilia A between May and July 2026. The core finding is a gap between clinical control and lived burden. 78% of medicated patients report good control, yet 46% still plan activities around bleed risk, and 44% are not on a prescribed medication at all. Interest in new options is near-universal at 95%. The report shows brand teams how to engage stable, evidence-led patients between treatment decisions.
Patient RecruitmentPatient IntelligencePatient Experience
Key Highlights
95% very interested in new treatment options
78% on medication report good bleed control
44% not on a prescribed medication
Overview
41 confirmed hemophilia A patients show that good bleed control does not remove daily burden, and interest in new options stays near-universal.
